Diagnosis and Management of Inflammatory and Infectious Diseases
Who can join
Ages 3 to 100 · All sexes
Full eligibility criteria
* INCLUSION CRITERIA: 1. Known or suspected exposure to infection, as determined by the Principal Investigator OR Presence of signs and symptoms of an infectious or inflammatory disease 2. Age range: 3 years of age and older. 3. NIAID/LIR investigator who has an interest in the patient s illness and is willing to serve as attending physician to supervise the patient's medical care at the NIH. 4. Primary physician outside the NIH 5. The patient or the patient's Legally Authorized Representative is capable of informed consent and signs the consent form. The consent form will be signed by parents or guardians of patients under the age of 18 EXCLUSION CRITERIA: 1. Pregnant. 2. Presence of conditions that, in the judgment of the investigator, may put the participant at undue risk or make them unsuitable for participation in the study.
About the study
This protocol is being established to cover the evaluation of patients with inflammatory and/or infectious diseases which are not covered under previously existing protocols. The purpose of such a protocol is that frequently patients are referred to us with either diagnosed or undiagnosed illnesses which would be of interest to our teaching program or which would serve as a source of patients to subsequently be entered into established, ongoing protocol studies. Such patients will be admitted to the protocol and handled according to accepted medical practice of diagnosis and treatment....
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) · Participants: 400 · Started: Feb 17, 1978
Contact the study team
- Rosemary McConnell, R.N. · Phone: (301) 827-9716
Official record on ClinicalTrials.gov — NCT00557726
Locations in the U.S.
| Maryland | National Institutes of Health Clinical Center, Bethesda |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.